All In Biotech

Drug Trial Radar · NCT00002549

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

RANDOMIZED PHASE III STUDY OF INDUCTION (ICE VS MICE VS DCE) AND INTENSIVE CONSOLIDATION (IDIA VS NOVIA VS DIA) FOLLOWED BY BONE MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA: AML 10 PROTOCOL

Last checked: Nov 19, 2026Latest source record: Dec 23, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 1,520 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

1,520

Planned (sponsor's estimate)

Start

Nov 1993

Primary completion

Not stated

Sponsor

Sponsor type
Research network
First posted
Jul 19, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Primary purpose
Treatment
Who can join
All sexes, from 15 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell or bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy followed by bone marrow or peripheral stem cell transplantation in treating patients with acute myelogenous leukemia.

Conditions

  • Leukemia

Interventions

  • filgrastimBiological

  • busulfanDrug

  • cyclophosphamideDrug

  • cytarabineDrug

  • daunorubicin hydrochlorideDrug

  • etoposideDrug

  • idarubicinDrug

  • mesnaDrug

  • mitoxantrone hydrochlorideDrug

  • allogeneic bone marrow transplantationProcedure

  • autologous bone marrow transplantationProcedure

  • peripheral blood stem cell transplantationProcedure

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

75 sites in 11 countries. Site status is shown where the registry gives one.

  • Universitaetsklinik

    Innsbruck, Austria

  • Algemeen Ziekenhuis Middelheim

    Antwerp, Belgium

  • A.Z. St. Jan

    Bruges, Belgium

  • Hopital Universitaire Erasme

    Brussels, Belgium

  • Institut Jules Bordet

    Brussels (Bruxelles), Belgium

  • Universitair Ziekenhuis Antwerpen

    Edegem, Belgium

  • CHU Sart-Tilman

    Liège, Belgium

  • University Hospital Rebro

    Zagreb, Croatia

  • Medical School/University of Zagreb

    Zagreb (Agram), Croatia

  • University Hospital - Olomouc

    Olomouc, Czechia

  • Institute of Hematology and Blood Transfusion

    Prague, Czechia

  • Hopital Edouard Herriot

    Lyon, France

  • Centre Antoine Lacassagne

    Nice, France

  • Hotel Dieu de Paris

    Paris, France

  • Hopital Cochin

    Paris, France

  • Hopital Necker

    Paris, France

  • Centre Medico-Chirurgical Foch

    Suresnes, France

  • Institut Gustave Roussy

    Villejuif, France

  • Staedtische Kliniken Duisburg

    Duisburg, Germany

  • Klinikum Grosshadern

    Munich (Muenchen), Germany

  • County Hospital

    Kecskemét, Hungary

  • Ospedale Civile Alessandria

    Alessandria, Italy

  • Ospedale Torrette University Ancona

    Ancona, Italy

  • Ospedale Civile Avellino

    Avellino, Italy

  • Universita Degli Studi di Bari Policlinico

    Bari, Italy

  • Ospedale Regionale A. Di Summa

    Brindisi, Italy

  • Ospedale Oncologico A. Businco

    Cagliari, Italy

  • Ospedale Ferrarotto

    Catania, Italy

  • Ospedale Regionale A. Pugliese

    Catanzaro, Italy

  • Centro Trapianti di Midollo Osseo

    Cremona, Italy

  • Ospedale Santa Croce

    Cuneo, Italy

  • Universita Degli Studi di Firenze - Policlin. di Careggi

    Firenze (Florence), Italy

  • Ospedali Riuniti Foggia

    Foggia, Italy

  • Ospedale S. Antonio Abate

    Gallarate Varese, Italy

  • Ospedale San Martino/Cliniche Universitarie Convenzionale

    Genoa (Genova), Italy

  • Ospedale Gen. Provinciale Santa Maria Goretti

    Latina, Italy

  • Ospedale Maggiore Lodi

    Lodi, Italy

  • Instituto Scientifico H.S. Raffaele

    Milano (Milan), Italy

  • Ospedale Maggiore Ca Granda

    Milano (Milan), Italy

  • Universita di Modena

    Modena, Italy

Showing 40 of 75 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.